Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 66.25% is 27% above its 5-year average of 52.19%, near the high end of its 5-year range (-287.32%–74.29%).
7.49% above its 12-month average of 61.64%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 63.64%.
GROSS MARGIN
66.25%
GROSS MARGIN AVG TTM
61.64%
GROSS MARGIN AVG 3Y
53.57%
GROSS MARGIN AVG 5Y
52.19%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+7.49%
CURRENT VS 3Y AVG
+23.66%
CURRENT VS 5Y AVG
+26.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+60.10%
vs the sector median at left
Tenon Medical, Inc.
Market Cap
$1.84M
Gross Margin
66.25%
TTM Avg
61.64%
3Y Avg
53.57%
5Y Avg
52.19%
Market Cap
$1.83M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.81M
Gross Margin
-27160.00%
TTM Avg
-15340.00%
3Y Avg
-31827.66%
5Y Avg
-23181.46%
Market Cap
$1.88M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.88M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.64M
Gross Margin
-1128.89%
TTM Avg
-518.50%
3Y Avg
-213.30%
5Y Avg
-126.70%
Market Cap
$2.13M
Gross Margin
-628.02%
TTM Avg
-265.21%
3Y Avg
-2905.33%
5Y Avg
-2576.02%
Market Cap
$2.14M
Gross Margin
59.72%
TTM Avg
60.22%
3Y Avg
60.72%
5Y Avg
66.21%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenon Medical, Inc. (TNON) | $1.84M | 66.25% | 61.64% | 53.57% | 52.19% |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | 4.18% | -20.80% | -38.59% | -9.06% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -27160.00% | -15340.00% | -31827.66% | -23181.46% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -1128.89% | -518.50% | -213.30% | -126.70% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | -628.02% | -265.21% | -2905.33% | -2576.02% |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | 59.72% | 60.22% | 60.72% | 66.21% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
66.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 63.64% |
| 2026-03-31 | 68.53% |
| 2025-12-31 | 66.67% |
| 2025-09-30 | 65.90% |
| 2025-06-30 | 43.44% |
| 2025-03-31 | 44.49% |
| 2024-12-31 | 45.84% |
| 2024-09-30 | 47.13% |
| 2024-06-30 | 52.16% |
| 2024-03-31 | 65.37% |
| 2023-12-31 | 50.50% |
| 2023-09-30 | 56.67% |
| 2023-06-30 | 26.11% |
| 2023-03-31 | -10.85% |
| 2022-12-31 | -74.73% |
| 2022-09-30 | -45.19% |
| 2022-06-30 | -100.74% |
| 2022-03-31 | -287.32% |
| 2021-12-31 | 68.23% |
| 2021-09-30 | 74.29% |
| 2021-06-30 | 59.09% |
| 2021-03-31 | 26.67% |
| 2020-12-31 | 32.08% |
| 2020-09-30 | 28.66% |
| 2020-06-30 | 74.81% |
| 2020-03-31 | 74.81% |
